1. Home
  2. KDLY vs COCP Comparison

KDLY vs COCP Comparison

Compare KDLY & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • COCP
  • Stock Information
  • Founded
  • KDLY 2019
  • COCP N/A
  • Country
  • KDLY United States
  • COCP United States
  • Employees
  • KDLY N/A
  • COCP N/A
  • Industry
  • KDLY
  • COCP Biotechnology: Pharmaceutical Preparations
  • Sector
  • KDLY
  • COCP Health Care
  • Exchange
  • KDLY NYSE
  • COCP Nasdaq
  • Market Cap
  • KDLY 19.6M
  • COCP 20.1M
  • IPO Year
  • KDLY 2024
  • COCP N/A
  • Fundamental
  • Price
  • KDLY $2.47
  • COCP $1.95
  • Analyst Decision
  • KDLY
  • COCP Strong Buy
  • Analyst Count
  • KDLY 0
  • COCP 1
  • Target Price
  • KDLY N/A
  • COCP $7.00
  • AVG Volume (30 Days)
  • KDLY 13.0M
  • COCP 31.5K
  • Earning Date
  • KDLY 03-04-2025
  • COCP 03-27-2025
  • Dividend Yield
  • KDLY N/A
  • COCP N/A
  • EPS Growth
  • KDLY N/A
  • COCP N/A
  • EPS
  • KDLY N/A
  • COCP N/A
  • Revenue
  • KDLY $2,875,400.00
  • COCP N/A
  • Revenue This Year
  • KDLY N/A
  • COCP N/A
  • Revenue Next Year
  • KDLY N/A
  • COCP N/A
  • P/E Ratio
  • KDLY N/A
  • COCP N/A
  • Revenue Growth
  • KDLY N/A
  • COCP N/A
  • 52 Week Low
  • KDLY $0.65
  • COCP $1.35
  • 52 Week High
  • KDLY $5.25
  • COCP $3.26
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • COCP 47.95
  • Support Level
  • KDLY N/A
  • COCP $1.75
  • Resistance Level
  • KDLY N/A
  • COCP $2.08
  • Average True Range (ATR)
  • KDLY 0.00
  • COCP 0.20
  • MACD
  • KDLY 0.00
  • COCP 0.00
  • Stochastic Oscillator
  • KDLY 0.00
  • COCP 45.07

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: